Biogen's (BIIB) Aducanumab Appears Further De-Risked - Jefferies
Go back to Biogen's (BIIB) Aducanumab Appears Further De-Risked - JefferiesBIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 201.99 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $201.99 | 52 Week High | $333.65 | |||
Open | $201.99 | 52 Week Low | $223.02 | |||
Day High | $201.99 | P/E | 25.86 | |||
Day Low | $201.99 | EPS | $7.81 | |||
Volume | 27 |